Arnaud Delpoux

Arnaud Delpoux

Auto-generated profile, based on publicly available information

Arnaud Delpoux

Molecular Biology Section, Department of Cellular and Molecular Medicine, University of California , San Diego, La Jolla, CA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Neuron
Verified
Journal Article
Closed access
JJJie Jiang
Jie Jiang
QZQiang Zhu
Qiang Zhu
TGTania F. Gendron
Tania F. Gendron
SSShahram Saberi
Shahram Saberi
MMMelissa McAlonis-Downes
Melissa McAlonis-Downes
CLClotilde Lagier-Tourenne
Clotilde Lagier-Tourenne

25 September 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JMJ. Justin Milner
J. Justin Milner
HNHongtuyet Nguyen
Hongtuyet Nguyen
KOKyla Omilusik
Kyla Omilusik
MRMiguel Reina-Campos
Miguel Reina-Campos
MTMatthew Tsai
Matthew Tsai
AGAnanda W. Goldrath
Ananda W. Goldrath
Significance: Memory CD8 T lymphocytes are a long-lived population of immune cells that provide formidable protection against infections and malignancy and are thus often central to vaccine and cancer immunotherapy efficacy. Here we refine the identity, developmental relationships, and functional roles of memory CD8 T cells in mice through delineation of a discrete population that confers robust protection against reinfection and exhibits an unexpected molecular program bearing typically divergent characteristics of short-lived effector cells and long-lived memory T cells. Mass cytometry and single-cell RNA-sequencing analyses revealed an analogous population of cells in humans. These findings hold broad implications for both informing immunotherapy treatments and predicting their efficacy.

31 July 2013 in Nature Communications
Verified
Journal Article
Closed access
PDF file
BMBruno Martin
Bruno Martin
CACédric Auffray
Cédric Auffray
ADArnaud Delpoux
Arnaud Delpoux
APArnaud Pommier
Arnaud Pommier
ADAurélie Durand
Aurélie Durand
BLBruno Lucas
Bruno Lucas

2 October 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ADArnaud Delpoux
Arnaud Delpoux
CLChen-Yen Lai
Chen-Yen Lai
SHStephen M. Hedrick
Stephen M. Hedrick
ADAndrew L. Doedens
Andrew L. Doedens
Significance: Acute infection with intracellular pathogen results in the expansion and effector differentiation of pathogen-specific CD8+T cells, most of which die after pathogen clearance. The factors and steps controlling CD8+T cell differentiation in response to acute infection are not fully understood. We find FOXO1 and TCF7 drive postinfection immune memory characteristics in cells expressing low TIM3, where TCF7 actively down-regulates the cytotoxic molecule GZMB and reduces terminally differentiated KLRG1higheffector abundance. We further report the creation of a continuum of CD8+T cell phenotypes, ranging from terminal effector cells to long-lived immune-memory cells, dependent on FOXO1 and TCF7. We conclude FOXO1 and TCF7 are essential to oppose cytotoxic/terminal differentiation programs and enable full phenotypic diversity of postinfection CD8+T cells.

27 December 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
ADArnaud Delpoux
Arnaud Delpoux
RMRodrigo Hess Michelini
Rodrigo Hess Michelini
SVShilpi Verma
Shilpi Verma
CLChen-Yen Lai
Chen-Yen Lai
KOKyla D. Omilusik
Kyla D. Omilusik
SHStephen M. Hedrick
Stephen M. Hedrick
Upon infection with an intracellular pathogen, cytotoxic CD8+ T cells develop diverse differentiation states characterized by function, localization, longevity, and the capacity for self-renewal. The program of differentiation is determined, in part, by FOXO1, a transcription factor known to integrate extrinsic input in order to specify survival, DNA repair, self-renewal, and proliferation. At issue is whether the state of T cell differentiation is specified by initial conditions of activation or is actively maintained. To study the spectrum of T cell differentiation, we have analyzed an infection with mouse cytomegalovirus, a persistent-latent virus that elicits different cytotoxic T cell responses characterized as acute resolving or inflationary. Our results show that FOXO1 is continuously required for all the phenotypic characteristics of memory-effector T cells such that with acute inactivation of the gene encoding FOXO1, T cells revert to a short-lived effector phenotype, exhibit reduced viability, and manifest characteristics of anergy.

22 July 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
APArnaud Pommier
Arnaud Pommier
AAAlexandra Audemard
Alexandra Audemard
ADAurélie Durand
Aurélie Durand
RLRenée Lengagne
Renée Lengagne
ADArnaud Delpoux
Arnaud Delpoux
APArmelle Prévost-Blondel
Armelle Prévost-Blondel
The present study evaluates the impact of immune cell populations on metastatic development in a model of spontaneous melanoma [mice expressing the human RET oncogene under the control of the metallothionein promoter (MT/ret mice)]. In this model, cancer cells disseminate early but remain dormant for several weeks. Then, MT/ret mice develop cutaneous metastases and, finally, distant metastases. A total of 35% of MT/ret mice develop a vitiligo, a skin depigmentation attributable to the lysis of normal melanocytes, associated with a delay in tumor progression. Here, we find that regulatory CD4+T cells accumulate in the skin, the spleen, and tumor-draining lymph nodes of MT/ret mice not developing vitiligo. Regulatory T-cell depletion and IL-10 neutralization led to increased occurrence of vitiligo that correlated with a decreased incidence of melanoma metastases. In contrast, inflammatory monocytes/dendritic cells accumulate in the skin of MT/ret mice with active vitiligo. Moreover, they inhibit tumor cell proliferation in vitro through a reactive oxygen species-dependent mechanism, and both their depletion and reactive oxygen species neutralization in vivo increased tumor cell dissemination. Altogether, our data suggest that regulatory CD4+T cells favor tumor progression, in part, by inhibiting recruitment and/or differentiation of inflammatory monocytes in the skin.